Where Are Cell Proteins Made

The Ribosome Question Nobody Asks Right

Most people who study biology for the first time get taught that proteins are "made in the ribosome" and leave it at that. It is not wrong, but it is dangerously incomplete. If you are actually working in a lab or trying to understand why your expression system is failing, the question Where Are Cell Proteins Made is the kind of thing that determines whether your experiment works or you spend three weeks troubleshooting something that should have been obvious. I spent way too much of my early career thinking about ribosomes as uniform little factories churning out the same product regardless of where they sit. That changed when I was working with a recombinant protein that refused to express at useful levels in E. coli, and the problem turned out to be fundamentally about topology rather than sequence. The protein wasn't misfolded because the amino acids were wrong. It was misfolded because the cell was making it in the wrong place.

Where Are Cell Proteins Made — The Real Answer

Proteins are synthesized by ribosomes, that part is non-negotiable. But ribosomes exist in two distinct locations inside a eukaryotic cell, and where a ribosome is sitting when it translates an mRNA strand determines the entire downstream fate of that protein. Free ribosomes float in the cytosol. They make proteins that will stay in the cytosol, go into the nucleus, get imported into mitochondria or peroxisomes, or become part of the cytoskeleton. These proteins are translated entirely in the cytoplasm and never cross a membrane during their synthesis. Membrane-bound ribosomes attach to the rough endoplasmic reticulum. They make proteins destined for secretion, for the plasma membrane, or for the lumen of the ER and downstream organelles in the endomembrane system — the Golgi, lysosomes, secretory vesicles. The key detail most people miss is that the attachment happens co-translationally. The ribosome does not finish making the protein and then move to the ER. It anchors to the ER while the polypeptide chain is still being built, threading the growing protein directly into the ER lumen or into the membrane itself.

There is also a third category that gets almost no attention outside specialized cell biology courses. Mitochondria and chloroplasts contain their own ribosomes and make a small subset of their own proteins internally. These are remnants of the endosymbiotic history of the cell. In human cells, the mitochondria encode about thirteen proteins out of roughly 1,500 that the organelle actually uses. The rest are imported from the cytosol after being made on free ribosomes.

How the Cell Decides Where to Build Things

The decision is not random. It is governed by a signal sequence at the N-terminus of the nascent polypeptide, called the signal recognition particle (SRP) pathway. When a ribosome starts translating an mRNA and the emerging chain includes an SRP-binding signal sequence, the ribosome-paulypeptide complex is paused briefly, captured by the signal recognition particle, and directed to the ER membrane. There it docks at the SRP receptor and the translocon channel (Sec61 in mammals) opens. Translation resumes and the protein flows through the channel. Proteins without that signal sequence stay on free ribosomes and are released directly into the cytosol. Simple, except it is not simple at all when you consider that some proteins have internal signal sequences rather than N-terminal ones, and some have signal-anchor sequences that actually anchor the protein in the membrane instead of threading it all the way through. I learned this the hard way. I was cloning a protein that appeared to be cytoplasmic based on the literature, but my immunofluorescence kept showing a reticular pattern consistent with ER localization. The mRNA had been misannotated. The protein actually carried a cryptic signal sequence that I had overlooked because I was looking at the mature protein sequence, not the full-length precursor. Once I cloned the correct isoform, the localization made perfect sense. This is one of those things that will burn you if you are not paying attention.

Post-Translational Reality

Synthesis is only the beginning. A protein emerging from a ribosome is rarely functional in its raw form. Once inside the ER lumen, proteins undergo glycosylation, disulfide bond formation catalyzed by protein disulfide isomerase, and initial folding assisted by chaperones like BiP and calnexin. The Golgi then modifies carbohydrate chains further and sorts proteins into their final destinations. If you are expressing a eukaryotic protein in a bacterial system, none of this happens. Bacteria lack the ER, the Golgi, and the glycosylation machinery. You get a properly sequenced polypeptide, possibly, but it will not be glycosylated, disulfide bonds may not form correctly in the reducing environment of the cytosol, and you may get inclusion bodies instead of soluble protein. I have spent entire quarters fighting solubility issues that came down to exactly this mismatch. The workaround was switching to a mammalian expression system even though it cost more time upfront, because the alternative was trying to refold tons of aggregated protein and usually failing. Cytosolic proteins do get post-translational modifications too. Phosphorylation, ubiquitination, acetylation, and methylation all happen in the cytosol or nucleus after translation. These modifications are often the actual regulatory switches, not the synthesis step itself.

Common Misunderstandings

One persistent misconception is that all proteins in a cell are made the same way and then shipped around. The location of synthesis is part of the protein's identity. A protein made on a free ribosome entering the nucleus uses a nuclear localization signal. A protein made on a ribosome attached to the ER enters the secretory pathway. The same amino acid sequence could theoretically end up in completely different cellular compartments depending on when and where the signal sequence is recognized, but in practice the signal sequence is encoded in the gene and the pathway is deterministic. Another misconception involves the idea that the Golgi "makes" proteins. It does not. The Golgi modifies and sorts. The actual peptide bond formation only happens at ribosomes. Period. You will see this mistake in introductory materials occasionally, and it compounds into bigger errors later on. There is also a bottleneck issue worth noting. The rate of protein synthesis in a typical mammalian cell is roughly 5 to 6 amino acids per second per ribosome, and a cell might contain somewhere between 10 million and 100 million ribosomes depending on its type and metabolic state. That gives you a sense of scale, but the actual throughput varies enormously. Secretory cells like pancreatic acinar cells or plasma cells producing antibodies have vastly more rough ER and far higher translation rates than, say, a resting lymphocyte.

Practical Takeaway

If you are designing an experiment involving protein expression, the first question you should answer is not which promoter to use or which tag to add. It is where in the cell this protein needs to function and whether your expression system can deliver it there correctly. A protein that folds properly in the ER of a HEK293 cell will not necessarily fold properly in the cytosol of E. coli, no matter how identical the coding sequence is. The cellular context of synthesis matters as much as the sequence itself.